Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1991-6-12
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0959-8049
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
342-9
|
pubmed:dateRevised |
2006-4-24
|
pubmed:meshHeading |
pubmed-meshheading:1851028-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:1851028-Carcinoma, Small Cell,
pubmed-meshheading:1851028-Hematopoietic Cell Growth Factors,
pubmed-meshheading:1851028-Humans,
pubmed-meshheading:1851028-Lung Neoplasms,
pubmed-meshheading:1851028-Prognosis
|
pubmed:year |
1991
|
pubmed:articleTitle |
Chemotherapy of small cell lung cancer.
|
pubmed:affiliation |
Finsen Institute, Department of Oncology, Righospitalet, Copenhagen, Denmark.
|
pubmed:publicationType |
Journal Article,
Review
|